Compare UVSP & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVSP | CDNA |
|---|---|---|
| Founded | 1876 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 983.8M | 1.0B |
| IPO Year | 1994 | 2007 |
| Metric | UVSP | CDNA |
|---|---|---|
| Price | $36.68 | $17.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $35.00 | $27.33 |
| AVG Volume (30 Days) | 167.1K | ★ 551.4K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.37% | N/A |
| EPS Growth | ★ 21.32 | N/A |
| EPS | ★ 3.13 | N/A |
| Revenue | ★ $328,056,000.00 | $48,324,000.00 |
| Revenue This Year | $11.65 | $16.01 |
| Revenue Next Year | $4.77 | $11.31 |
| P/E Ratio | $11.88 | ★ N/A |
| Revenue Growth | 9.64 | ★ 18.93 |
| 52 Week Low | $26.54 | $10.96 |
| 52 Week High | $37.72 | $21.49 |
| Indicator | UVSP | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 50.52 |
| Support Level | $32.00 | $16.63 |
| Resistance Level | N/A | $19.02 |
| Average True Range (ATR) | 0.76 | 1.00 |
| MACD | 0.27 | 0.06 |
| Stochastic Oscillator | 77.61 | 65.22 |
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.